tradingkey.logo
๎™๊ฒ€์ƒ‰
์‹œ์žฅ
๊ด€์‹ฌ ๋ชฉ๋ก
๋‰ด์Šค
๋ถ„์„
๋„๊ตฌ
์ข…๋ชฉ ์Šคํฌ๋ฆฌ๋„ˆ
๎™ผ
๎˜
English
็นไฝ“ไธญๆ–‡
เน„เธ—เธข
Tiแบฟng viแป‡t
็ฎ€ไฝ“ไธญๆ–‡
Espaรฑol
Portuguรชs
Deutsch
ํ•œ๊ตญ์–ด
๎˜ณ
ๆ—ฅๆœฌ่ชž
tradingkey.logo
๎™๊ฒ€์ƒ‰
๎™
๎˜

Larimar Therapeutics Inc

LRMR
๎˜ญ๊ด€์‹ฌ ๋ชฉ๋ก์— ์ถ”๊ฐ€
3.820USD
-0.005-0.13%
์ข…๊ฐ€ย 07-31 16:00๏ผˆET๏ผ‰์‹œ์„ธ๋Š” 15๋ถ„ ์ง€์—ฐ๋ฉ๋‹ˆ๋‹ค
396.83M์‹œ๊ฐ€์ด์•ก
์†์‹คP/E TTM

Larimar Therapeutics Inc

3.820
-0.005-0.13%
๊ฐœ์š”
๊ธˆ์œต
ํ† ๋ก 
๋ถ„์„
ํšŒ์‚ฌ
์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

๊ฐœ์š”

๊ธˆ์œต

ํ† ๋ก 

๋ถ„์„

ํšŒ์‚ฌ

์žฌ๋ฌด ์š”์•ฝ์†์ต๊ณ„์‚ฐ์„œ์žฌ๋ฌด์ƒํƒœํ‘œํ˜„๊ธˆ ํ๋ฆ„ํ‘œ

LRMR ์žฌ๋ฌด ๋ฐ์ดํ„ฐ

์Šค๋งˆํŠธํ•œ ํˆฌ์ž์ž๋ฅผ ์œ„ํ•ด ์„ค๊ณ„๋œ ์˜ฌ์ธ์› ๋ฐ์ดํ„ฐ ๋Œ€์‹œ๋ณด๋“œ๋ฅผ ํ†ตํ•ด Larimar Therapeutics Inc์˜ ์žฌ๋ฌด ๋ฐ์ดํ„ฐ๋ฅผ ํ™•์ธํ•˜์„ธ์š”. ๋ณต์žกํ•œ ์žฌ๋ฌด์ œํ‘œ๋ฅผ ์‚ฌ์šฉ์ž ์ •์˜ ๊ฐ€๋Šฅํ•œ ๋ทฐ๋กœ ๊ตฌ์„ฑํ•˜์—ฌ ์žฌ๋ฌด ๋ถ„์„์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. ์ตœ์‹  ์—ฐ๊ฐ„ ์žฌ๋ฌด ๋ณด๊ณ ์„œ์— ์ ‘๊ทผํ•˜๊ฑฐ๋‚˜, ์†์ต๊ณ„์‚ฐ์„œ, ์žฌ๋ฌด์ƒํƒœํ‘œ, ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๋ฅผ ์‚ฌ์šฉํ•˜์—ฌ ๋ถ„๊ธฐ๋ณ„ ์„ฑ๊ณผ๋ฅผ ๋ถ„์„ํ•˜์„ธ์š”. ์‹ค์‹œ๊ฐ„ ์žฌ๋ฌด ์ง€ํ‘œ๋ฅผ ์†๋์—์„œ ํ™•์ธํ•  ์ˆ˜ ์žˆ์–ด ํšŒ์‚ฌ์˜ ์‹œ์žฅ ๊ฑด์ „์„ฑ์„ ์‹œ๊ฐ„์— ๋”ฐ๋ผ ๊ทธ ์–ด๋Š ๋•Œ๋ณด๋‹ค ์‰ฝ๊ฒŒ ๋ชจ๋‹ˆํ„ฐ๋งํ•  ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.

Larimar Therapeutics Inc ์‹ค์  ๋ฐœํ‘œ์ผ

์ตœ์‹  ์ถœ์‹œ
May 14, 2026
EPS / ์˜ˆ์ƒ
-0.33/-0.54
์ˆ˜์ต / ์˜ˆ์ƒ
--/0.00
์˜ˆ์ •๋œ ์‹ค์  ๋ฐœํ‘œ ์ผ์ • ๋ณด๊ธฐ >>
์ฃผ๊ธฐ
FY2025 ์žฌ๋ฌด์ œํ‘œ
์ˆ˜์ต(YoY)
--
--
EPS(YoY)
-2.27
-72.60%
์• ๋„๋ฆฌ์ŠคํŠธ ํ‰๊ฐ€
STRONG BUY
2026/08/02
๋ถ„๊ธฐ๋ณ„๎˜ฎ
๋ถ„๊ธฐ๋ณ„+์—ฐ๊ฐ„
๋ถ„๊ธฐ๋ณ„
์—ฐ๊ฐ„
YOY
๋นˆ ํ–‰ ์ˆจ๊ธฐ๊ธฐ
FY2026Q1
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
์žฌ๋ฌด ์ง€ํ‘œ
EPS
27.97%-0.33
-62.21%-0.73
-150.78%-0.61
-20.64%-0.41
-67.30%-0.46
-52.61%-0.45
-17.66%-0.24
-77.86%-0.34
-84.06%-0.27
-38.46%-0.30
---0.21
---0.19
---0.15
---0.21
---1.32
----
----
----
----
----
์ˆœ์ด์ต
-1.13%-29.61M
-116.83%-62.50M
-207.84%-47.71M
-21.06%-26.18M
-99.82%-29.28M
-121.84%-28.82M
-71.00%-15.50M
-158.51%-21.63M
-124.55%-14.65M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
-3.19%-9.43M
50.49%-8.32M
31.26%-8.67M
26.02%-8.94M
35.69%-9.13M
-63.57%-16.80M
-11.29%-12.61M
์†์ต๊ณ„์‚ฐ์„œ๎˜
์˜์—… ์ด์ต
0.23%-31.12M
-104.58%-64.02M
-171.02%-49.50M
-12.98%-27.79M
-86.38%-31.19M
-120.96%-31.29M
-76.65%-18.26M
-155.71%-24.60M
-119.12%-16.73M
-35.66%-14.16M
-21.45%-10.34M
-10.74%-9.62M
14.07%-7.64M
-14.89%-10.44M
49.12%-8.51M
30.74%-8.69M
26.59%-8.89M
36.89%-9.09M
-61.88%-16.73M
-10.04%-12.54M
์ˆœ์ด์ต
-1.13%-29.61M
-116.83%-62.50M
-207.84%-47.71M
-21.06%-26.18M
-99.82%-29.28M
-121.84%-28.82M
-71.00%-15.50M
-158.51%-21.63M
-124.55%-14.65M
-37.86%-12.99M
-8.94%-9.06M
3.47%-8.37M
27.03%-6.53M
-3.19%-9.43M
50.49%-8.32M
31.26%-8.67M
26.02%-8.94M
35.69%-9.13M
-63.57%-16.80M
-11.29%-12.61M
์žฌ๋ฌด์ƒํƒœํ‘œ๎˜
์œ ๋™์ž์‚ฐ
23.86%204.98M
-27.28%142.02M
-14.08%183.22M
-37.02%145.56M
-28.35%165.49M
116.58%195.30M
116.55%213.26M
117.07%231.13M
103.55%230.95M
-25.31%90.17M
-22.53%98.48M
87.65%106.48M
74.89%113.46M
67.22%120.74M
56.46%127.13M
-23.36%56.74M
-24.67%64.88M
-26.29%72.20M
-24.64%81.25M
-37.84%74.04M
์œ ๋™ ๋ถ€์ฑ„ ์ด๊ณ„
115.76%47.76M
166.03%64.80M
177.04%45.12M
25.97%26.65M
72.37%22.13M
156.22%24.36M
148.32%16.29M
190.79%21.16M
60.31%12.84M
-11.20%9.51M
-30.38%6.56M
-5.75%7.28M
-9.73%8.01M
21.02%10.71M
-8.60%9.42M
0.36%7.72M
5.95%8.87M
-1.62%8.85M
99.03%10.31M
15.74%7.69M
์ด ์ž์‚ฐ
22.53%208.51M
-27.16%145.84M
-14.46%187.35M
-36.76%149.99M
-31.44%170.18M
108.71%200.22M
110.69%219.02M
112.29%237.16M
108.74%248.21M
-24.11%95.94M
-21.85%103.95M
77.74%111.72M
66.95%118.91M
60.68%126.41M
51.26%133.01M
-22.34%62.85M
-23.43%71.22M
-24.85%78.67M
-22.83%87.94M
-35.49%80.93M
๋ถ€์ฑ„ ์ด๊ณ„
94.87%50.48M
138.47%67.76M
134.29%48.31M
16.99%30.13M
49.21%25.90M
99.88%28.41M
83.46%20.62M
118.55%25.76M
37.07%17.36M
-8.30%14.21M
-21.69%11.24M
-7.89%11.79M
-10.28%12.67M
8.76%15.50M
-9.56%14.35M
-4.55%12.80M
-0.82%14.12M
-4.94%14.25M
40.25%15.87M
3.82%13.41M
์ž๋ณธ ์ด๊ณ„
9.54%158.03M
-54.55%78.08M
-29.92%139.04M
-43.31%119.85M
-37.50%144.27M
110.24%171.81M
114.00%198.40M
111.55%211.40M
117.28%230.84M
-26.31%81.72M
-21.87%92.71M
99.64%99.93M
86.05%106.24M
72.17%110.90M
64.66%118.66M
-25.87%50.06M
-27.52%57.10M
-28.18%64.41M
-29.79%72.07M
-40.00%67.53M
ํ˜„๊ธˆ ํ๋ฆ„ํ‘œ๎˜
์ˆœ์˜์—…์ด์ต
-68.10%-44.61M
-76.61%-38.53M
-17.14%-28.75M
-38.55%-19.38M
-154.92%-26.54M
-133.49%-21.82M
-166.80%-24.55M
-89.93%-13.99M
-37.88%-10.41M
-40.03%-9.34M
-56.52%-9.20M
1.62%-7.37M
-0.24%-7.55M
15.74%-6.67M
51.82%-5.88M
30.57%-7.49M
32.78%-7.53M
19.67%-7.92M
-8.71%-12.20M
34.67%-10.78M
์ˆœํˆฌ์ž
100.72%29.00M
77.11%34.00M
21.07%33.02M
129.68%18.84M
121.13%14.45M
830.20%19.20M
158.74%27.27M
-545.38%-63.49M
-174.11%-68.36M
94.97%-2.63M
-1272.04%-46.43M
72.16%-9.84M
--92.25M
-904.84%-52.23M
50.17%-3.38M
-283.89%-35.34M
-100.00%0.00
127.56%6.49M
-84787.50%-6.79M
-14.39%19.22M
์ˆœ์žฌ๋ฌดํ™œ๋™
--108.11M
-658.33%-201.00K
217523.33%65.29M
100.00%0.00
-100.00%0.00
--36.00K
0.00%30.00K
---334.00K
--162.15M
100.00%0.00
-99.96%30.00K
----
--0.00
---316.00K
280.05%75.57M
--0.00
--0.00
-100.00%0.00
14829.63%19.89M
-100.00%0.00

์ž์ฃผ ๋ฌป๋Š” ์งˆ๋ฌธ

Larimar Therapeutics Inc์˜ ์œ ๋™์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์œ ๋™์ž์‚ฐ์€ 142.02M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -27.28์ž…๋‹ˆ๋‹ค.

Larimar Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Larimar Therapeutics Inc์˜ ์ด์ž์‚ฐ์€ 145.84M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -27.16์ž…๋‹ˆ๋‹ค.

Larimar Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Larimar Therapeutics Inc์˜ ์ด๋ถ€์ฑ„๋Š” 67.76M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 138.47์ž…๋‹ˆ๋‹ค.

Larimar Therapeutics Inc์˜ ์ด์ž๋ณธ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Larimar Therapeutics Inc์˜ ์ด์ž๋ณธ์€ 78.08M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -54.55์ž…๋‹ˆ๋‹ค.

Larimar Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Larimar Therapeutics Inc์˜ ์ˆœ์˜์—…์†Œ๋“์€ -172.50M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -89.79์ž…๋‹ˆ๋‹ค.

Larimar Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Larimar Therapeutics Inc์˜ ์ˆœํˆฌ์ž๋Š” 100.31M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” 217.48์ž…๋‹ˆ๋‹ค.

Larimar Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, Larimar Therapeutics Inc์˜ ์ˆœ์ž๊ธˆ์กฐ๋‹ฌ์€ 65.09M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -59.79์ž…๋‹ˆ๋‹ค.

Larimar Therapeutics Inc์˜ ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ฃผ๋‹น์ˆœ์ด์ต(EPS)์€ -2.27์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -72.60์ž…๋‹ˆ๋‹ค.

Larimar Therapeutics Inc์˜ ์ˆœ์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ˆœ์ด์ต์€ -165.67M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -105.54์ž…๋‹ˆ๋‹ค.

Larimar Therapeutics Inc์˜ ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ž๊ธฐ์ž๋ณธ์ด์ต๋ฅ (ROE)์€ -132.59์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -108.53์ž…๋‹ˆ๋‹ค.

Larimar Therapeutics Inc์˜ ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์ด์ž์‚ฐ์ด์ต๋ฅ (ROA)์€ -95.75์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -75.90์ž…๋‹ˆ๋‹ค.

Larimar Therapeutics Inc์˜ ์˜์—…์ด์ต์€ ์–ผ๋งˆ์ธ๊ฐ€์š”?

๎™Œ
Larimar Therapeutics Inc์˜ FY2025 ์‹ค์  ๋ณด๊ณ ์„œ์— ๋”ฐ๋ฅด๋ฉด, ์˜์—…์ด์ต์€ -172.50M์ด๋ฉฐ, ์ „๋…„ ๋Œ€๋น„ ๋ณ€๋™์น˜๋Š” -89.79์ž…๋‹ˆ๋‹ค.
tradingkey.logo
์œ„ํ—˜ ๊ฒฝ๊ณ : ์ €ํฌ ์›น์‚ฌ์ดํŠธ์™€ ๋ชจ๋ฐ”์ผ ์•ฑ์€ ํŠน์ • ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ผ๋ฐ˜์ ์ธ ์ •๋ณด๋งŒ์„ ์ œ๊ณตํ•ฉ๋‹ˆ๋‹ค. Finsights๋Š” ์žฌ์ •์  ์กฐ์–ธ์ด๋‚˜ ํˆฌ์ž ์ƒํ’ˆ์— ๋Œ€ํ•œ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜์ง€ ์•Š์œผ๋ฉฐ, ์ด๋Ÿฌํ•œ ์ •๋ณด ์ œ๊ณต์ด Finsights๊ฐ€ ๊ธˆ์œต ์กฐ์–ธ์ด๋‚˜ ์ถ”์ฒœ์„ ์ œ๊ณตํ•˜๋Š” ๊ฒƒ์œผ๋กœ ํ•ด์„๋˜์–ด์„œ๋Š” ์•ˆ ๋ฉ๋‹ˆ๋‹ค.
ํˆฌ์ž ์ƒํ’ˆ์€ ํˆฌ์ž ์›๊ธˆ ์†์‹ค์„ ํฌํ•จํ•œ ์ƒ๋‹นํ•œ ํˆฌ์ž ์œ„ํ—˜์— ๋…ธ์ถœ๋˜์–ด ์žˆ์œผ๋ฉฐ, ๋ชจ๋“  ์‚ฌ๋žŒ์—๊ฒŒ ์ ํ•ฉํ•˜์ง€ ์•Š์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค. ํˆฌ์ž ์ƒํ’ˆ์˜ ๊ณผ๊ฑฐ ์„ฑ๊ณผ๋Š” ๋ฏธ๋ž˜ ์„ฑ๊ณผ๋ฅผ ๋ณด์žฅํ•˜์ง€ ์•Š์Šต๋‹ˆ๋‹ค.
Finsights๋Š” ์ œ3์ž ๊ด‘๊ณ ์ฃผ๋‚˜ ์ œํœด์‚ฌ๊ฐ€ ์ €ํฌ ์›น์‚ฌ์ดํŠธ๋‚˜ ๋ชจ๋ฐ”์ผ ์•ฑ ๋˜๋Š” ๊ทธ ์ผ๋ถ€์— ๊ด‘๊ณ ๋ฅผ ๊ฒŒ์žฌํ•˜๊ฑฐ๋‚˜ ์ „๋‹ฌํ•  ์ˆ˜ ์žˆ๋„๋ก ํ—ˆ์šฉํ•  ์ˆ˜ ์žˆ์œผ๋ฉฐ, ์‚ฌ์šฉ์ž๊ฐ€ ๊ด‘๊ณ ์™€ ์ƒํ˜ธ์ž‘์šฉํ•˜๋Š” ๋ฐฉ์‹์— ๋”ฐ๋ผ ์ด๋“ค๋กœ๋ถ€ํ„ฐ ๋ณด์ƒ์„ ๋ฐ›์„ ์ˆ˜ ์žˆ์Šต๋‹ˆ๋‹ค.
ยฉ ์ €์ž‘๊ถŒ: FINSIGHTS MEDIA PTE. LTD. ๋ชจ๋“  ๊ถŒ๋ฆฌ ๋ณด์œ 
์ด์šฉ ์•ฝ๊ด€
๊ฐœ์ธ์ •๋ณด ์ฒ˜๋ฆฌ๋ฐฉ์นจ
์ฟ ํ‚ค ์ •์ฑ